Drug ID: | NPD4184 |
Drug Name: | |
Molecular Formula: | C20H28N4O4 |
Canonical SMILES: | CN=C([C@H](Cc1c[nH]c2c1cccc2)N=C([C@@H](CC(=NO)O)CC(C)C)O)O |
Standard InCHI: | InChI=1S/C20H28N4O4/c1-12(2)8-13(10-18(25)24-28)19(26)23-17(20(27)21-3)9-14-11-22-16-7-5-4-6-15(14)16/h4-7,11-13,17,22,28H,8-10H2,1-3H3,(H,21,27)(H,23,26)(H,24,25)/t13-,17+/m1/s1 |
Standard InCHIKey: | NITYDPDXAAFEIT-DYVFJYSZSA-N |
Max Developmental Stage: | Clinical (unspecified phase) |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DPR000165; DNC003010; DNC003714 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | 132519 |
ChEBI | |
CAS Number |
Molecular Weight | 388.21 |
ALogP | -0.5848 |
MLogP | 2.78 |
XLogP | 3.588 |
HDA | 6 |
HBD | 5 |
Rotatable Bonds | 16 |
TPSA | 133.79 |
RO5 Violation | 0 |